Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
House debates expanding Prescription Drug Affordability Board powers; bill special-ordered for amendment
Summary
The Maryland House of Delegates on Feb. 18 debated House Bill 424, which would expand the Prescription Drug Affordability Board’s power to set upper payment limits and, after a pilot, apply those limits to the commercial insurance market.
The Maryland House of Delegates on Feb. 18 debated House Bill 424, a measure that would expand the Prescription Drug Affordability Board’s authority to set upper payment limits and, contingent on a pilot, apply that authority to the commercial insurance market.
Floor Leader (Floor Leader) summarized the bill’s purpose and contingency: the board, created under a 2019 law, is preparing affordability analyses of selected drugs and may set upper payment limits as one tool to control rising prescription costs. “Upper payment limits are not price caps,” the Floor Leader said. “What they are is what we as a state can…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
